Our Pipeline

Flexion’s strategy is to build a robust pipeline of locally administered therapies to address musculoskeletal conditions, with an initial focus on osteoarthritis (OA) and post-operative pain.

The information contained on this website reflects Flexion Therapeutics’ clinical development program as of March 1, 2021, and is not intended for promotional purposes. There can be no guarantee that any clinical development program reaches completion or that any indication or investigational therapy receives regulatory approval.